Open Orphan is trading at 0.0861 as of the 23rd of January 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.0861. Open Orphan has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 25th of October 2025 and ending today, the 23rd of January 2026. Click here to learn more.
Open Orphan Plc operates as a pharmaceutical service and contract research company. Further, the company provides preclinical and early clinical research services sales and marketing services and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC , and PK and medical writing to a range of European clients. The company has 671.05 M outstanding shares. More on Open Orphan plc
Open Orphan plc [OPORF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 96.91 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Open Orphan's market, we take the total number of its shares issued and multiply it by Open Orphan's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Open Orphan plc classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 671.05 M outstanding shares.
Open Orphan plc has accumulated about 15.93 M in cash with (1.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check Open Orphan Probability Of BankruptcyOwnership AllocationOpen Orphan owns a total of 671.05 Million outstanding shares. Open Orphan has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Open Ownership Details
About 41.0% of the company outstanding shares are owned by corporate insiders. The book value of Open Orphan was now reported as 0.03. The company had not issued any dividends in recent years. Open Orphan Plc operates as a pharmaceutical service and contract research company. Further, the company provides preclinical and early clinical research services sales and marketing services and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC , and PK and medical writing to a range of European clients. Open Orphan is traded on OTC Exchange in the United States.The quote for Open Orphan plc is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Open Orphan plc contact Yamin Khan at 44 20 7756 1300 or learn more at https://www.hvivo.com.
Open Orphan plc Investment Alerts
Open Orphan plc generated a negative expected return over the last 90 days
Open Orphan plc has some characteristics of a very speculative penny stock
The company reported the revenue of 36.86 M. Net Loss for the year was (74 K) with profit before overhead, payroll, taxes, and interest of 4.29 M.
Open Orphan plc has accumulated about 15.93 M in cash with (1.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Roughly 41.0% of the company outstanding shares are owned by corporate insiders
Open Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 96.91 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Open Orphan's market, we take the total number of its shares issued and multiply it by Open Orphan's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Open Profitablity
The company has Profit Margin (PM) of (0.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.01 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.01.
Technical Drivers
As of the 23rd of January, Open Orphan holds the Coefficient Of Variation of (812.40), variance of 62.3, and Risk Adjusted Performance of (0.08). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Open Orphan, as well as the relationship between them. Please check Open Orphan plccoefficient of variation and maximum drawdown to decide if Open Orphan plc is priced some-what accurately, providing market reflects its current price of 0.0861 per share. As Open Orphan plc appears to be a penny stock we also advise to check out its information ratio numbers.
The output start index for this execution was zero with a total number of output elements of sixty-one. Open Orphan plc Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Open Orphan price patterns.
Open Orphan Predictive Daily Indicators
Open Orphan intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Open Orphan pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Open Orphan's time-series forecasting models are one of many Open Orphan's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Open Orphan's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in Open Orphan without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Headlines Timeline Now
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Open Orphan financial ratios help investors to determine whether Open Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Open with respect to the benefits of owning Open Orphan security.